Biochemical and structural studies of distinct conformational states of gp41
Biochemical and structural studies of distinct conformational states of gp41
批准号:
7790795
负责人:
Bing Chen
金额:
$35.23万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2014-03-31
关键词:
AIDS VaccinesAcquired Immunodeficiency SyndromeAffinity ChromatographyAntibodiesAntiviral AgentsBindingBiochemicalBiological AssayCell membraneCellsCharacteristicsComplementComplexCrystallizationDataDetergentsDevelopmentElectron MicroscopyElectronsEpidemicEpitopesEscherichia coliGenerationsGlycoproteinsGoalsHIVHIV Envelope Protein gp120HIV-1ImageImmune responseIn VitroInsectaKnowledgeLifeLightMediatingMembraneMembrane FusionModelingMolecularMolecular ConformationMutagenesisMutateNMR SpectroscopyPathway interactionsPeptidesPreparationProductionPropertyProteinsRecombinantsResidual stateResolutionSIVSIV envelope protein gp41Screening procedureSeriesSiteStructureSurfaceTestingTherapeuticTransmembrane DomainUpdateVaccinesViralVirionVirus Receptorsbaseconformational conversiondesignenv Gene Productsglycosylationin vivoinhibitor/antagonistinsightneutralizing antibodyprotein S precursorprotein structurepublic health relevancereceptorresearch studyretinal rodssimian immunodeficiency virus gp120therapeutic vaccineurinary gonadotropin fragmentvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The envelope glycoproteins of HIV/SIV, assembled as a (gp120/gp41)3 trimeric complex, mediate viral attachment and membrane fusion. Biochemical and structural studies have provided a general picture of how binding to viral receptor and co-receptor triggers a cascade of fusion-promoting conformational changes. Understanding of HIV/SIV Env conformations at the atomic level has come mainly from three sets of crystal structures: that of an unliganded SIV gp120 core fragment, those of receptor-induced conformations of the HIV gp120 core, and those of the postfusion form of HIV and SIV gp41. The conformation of the native (gp120/gp41)3 on the surface of the virion, especially that of its gp41 component, remains unknown, except for some low-resolution images from electron microscopy. We also lack a proper picture of an important intermediate in the pathway from the prefusion to postfusion conformation of gp41 - the so-called "prehairpin intermediate" that is the target of T-20/Entfuvirtide (the first approved fusion-inhibiting antiviral drug) and of certain broadly neutralizing antibodies, as we describe in the Preliminary Data. Filling these gaps in our knowledge of envelope protein structures will guide development of vaccines and therapeutics. Moreover, production of stable, homogeneous preparations of recombinant gp41 in defined conformations will help us understand structural correlates for neutralization, even in the absence of high-resolution structures. In this proposal, we will explore the hypothesis that the various conformational states of gp41 hold key to our understanding of fusion mechanism and antibody neutralization by biochemical and structural approaches. We propose here to study gp41 in its prefusion, fusion-intermediate, and postfusion conformations, with structural information as our ultimate goal. We will build upon preliminary results that show we can express and characterize suitable forms of each. In particular, we will pursue the following specific aims: 1. To carry out biochemical and structural studies of the "prehairpin intermediate" of gp41; 2. To characterize gp41 in the prefusion conformation and determine its structure; 3. To study the conformation of the membrane-interacting segments of gp41 in the postfusion state. PUBLIC HEALTH RELEVANCE: Nearly 40 million people are living with human immunodeficiency virus (HIV) and 4 million people are newly infected with HIV in 2006 alone (UNAIDS/WHO AIDS epidemic update, 2006). An effective vaccine is urgently needed to stop this epidemic. The proposed studies will allow us to visualize in great detail the organization of the viral envelope glycoprotein, which is the main target by host immune responses and by some new-generation antiviral drugs, called fusion inhibitors. The information obtained from these experiments is expected to guide development of both AIDS vaccine and antiviral therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploring the membrane-related components of HIV-1 Env for immunogen design
-
批准号:10762577
-
项目类别:
-
资助金额:$84.19万
-
财政年份:2023
-
负责人:Bing Chen
-
依托单位:
Structure of HIV-1 envelope spike in the context of membrane
-
批准号:10322988
-
项目类别:
-
资助金额:$71.03万
-
财政年份:2020
-
负责人:Bing Chen
-
依托单位:
Structure of HIV-1 envelope spike in the context of membrane
-
批准号:10538590
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2020
-
负责人:Bing Chen
-
依托单位:
Structure of the full-length spike protein of SARS-CoV-2 in the context of membrane
-
批准号:10117733
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2020
-
负责人:Bing Chen
-
依托单位:
Structure of HIV-1 envelope spike in the context of membrane
-
批准号:10013609
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2020
-
负责人:Bing Chen
-
依托单位:
Structural Basis of Coreceptor Recognition by HIV-1 Envelope Spike
-
批准号:9906847
-
项目类别:
-
资助金额:$52.6万
-
财政年份:2018
-
负责人:Bing Chen
-
依托单位:
Structural Basis of Coreceptor Recognition by HIV-1 Envelope Spike
-
批准号:10390469
-
项目类别:
-
资助金额:$52.18万
-
财政年份:2018
-
负责人:Bing Chen
-
依托单位:
Novel therapeutics targeting the membrane proximal external region of HIV-1 Env
-
批准号:9513722
-
项目类别:
-
资助金额:$67.38万
-
财政年份:2017
-
负责人:Bing Chen
-
依托单位:
Structure-function studies of the membrane-interacting domains of HIV-1 Env spike
-
批准号:10653205
-
项目类别:
-
资助金额:$81.62万
-
财政年份:2016
-
负责人:Bing Chen
-
依托单位:
Structure-function studies of the membrane-interacting domains of HIV-1 Env spike
-
批准号:10449192
-
项目类别:
-
资助金额:$81.61万
-
财政年份:2016
-
负责人:Bing Chen
-
依托单位:
Small-Molecule Fusion Inhibitors Targeting a Fusion Intermediate State of HIV-1 g
-
批准号:8901482
-
项目类别:
-
资助金额:$43.96万
-
财政年份:2014
-
负责人:Bing Chen
-
依托单位:
Crystallographic studies of intact and fully glycosylated HIV-1 gp120
-
批准号:8603481
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2013
-
负责人:Bing Chen
-
依托单位:
Crystallographic studies of intact and fully glycosylated HIV-1 gp120
-
批准号:8663835
-
项目类别:
-
资助金额:$44.15万
-
财政年份:2013
-
负责人:Bing Chen
-
依托单位:
Crystallographic studies of intact and fully glycosylated HIV-1 gp120
-
批准号:9053443
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:Bing Chen
-
依托单位:
Crystallographic studies of intact and fully glycosylated HIV-1 gp120
-
批准号:8836951
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2013
-
负责人:Bing Chen
-
依托单位:
HIV-1 GP41 ARE RECOGNIZED BY NEUTRALIZING AND NON-NEUTRALIZING ANTIBODIES
-
批准号:8361720
-
项目类别:
-
资助金额:$0.26万
-
财政年份:2011
-
负责人:Bing Chen
-
依托单位:
HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
-
批准号:8361719
-
项目类别:
-
资助金额:$0.25万
-
财政年份:2011
-
负责人:Bing Chen
-
依托单位:
Biochemical and structural studies of distinct conformational states of gp41
-
批准号:8055554
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2009
-
负责人:Bing Chen
-
依托单位:
Biochemical and structural studies of distinct conformational states of gp41
-
批准号:8243563
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2009
-
负责人:Bing Chen
-
依托单位:
Biochemical and structural studies of distinct conformational states of gp41
-
批准号:8440765
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2009
-
负责人:Bing Chen
-
依托单位:
海外基金